Michael J. Boeckh - Vaccines

Author Information

Michael Boeckh is a prominent researcher affiliated with the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Center in Seattle, WA, USA. His extensive work primarily revolves around infectious diseases, with a particular focus on respiratory viruses and their impact on immunocompromised patients, including those undergoing hematopoietic stem cell transplantation.

Research Contributions

Michael Boeckh has made significant contributions to the understanding of infectious diseases in immunocompromised patients. His research has explored various aspects of respiratory viruses, including their interactions, disease progression, and impact on patients with preexisting conditions. Boeckh's work is crucial in developing predictive factors and treatment strategies for viral infections in vulnerable populations. Notably, his recent studies have addressed the phylogenomics of SARS-CoV-2 in emergency shelters and trends in COVID-19 vaccination intent among homeless shelter residents and staff.

Aliases

Michael Boeckh is also known by several aliases in the academic community, including M Boeckh, Michael J. Boeckh, Michael A. Boeckh, M J Boeckh, and M. Boeckh.

Publication and Citation Metrics

Publication Count	621
Citation Count	42,910
h-index	110

Publications:

Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients

DOI: 10.1073/pnas.2117031119

Year: 2022

Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes.

DOI: 10.1182/bloodadvances.2021004915

Year: 2022

Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data

DOI: 10.1101/2022.02.04.22270474

Year: 2022

Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.

DOI: 10.1016/j.jcv.2022.105152

Year: 2022

Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients

DOI: 10.1038/s41409-022-01575-z

Year: 2022

Phylogenomics of SARS-CoV-2 in Emergency Shelters for People Experiencing Homelessness

DOI: 10.1093/infdis/jiac021

Year: 2022

Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 – King County, Washington

DOI: 10.1016/j.vaccine.2021.11.026

Year: 2021

Association of inherited chromosomally integrated human herpesvirus 6 with neurologic symptoms and management after allogeneic hematopoietic cell transplantation.

DOI: 10.1016/j.jtct.2021.05.029

Year: 2021

Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation

DOI: 10.1182/bloodadvances.2020003865

Year: 2021

DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study

DOI: 10.1093/cid/ciab113

Year: 2021

Are Booster Doses Necessary?

How can Technology Aid in Monitoring Vaccination Coverage?

Why is Vaccine Efficacy Important?

How Do Genetically Engineered Vaccines Work?

What Role Do Genetic Variability Play in Emerging Infectious Diseases?

Who Should Get the Hib Vaccine?

Which vaccines are included in EPI?

Why are Booster Shots Necessary?

How Do They Work?

What is AS01 (Mosquirix)?

Partnered Content Networks

Relevant Topics